Scinopharm Taiwan (TPE:1789) COGS-to-Revenue : 0.60 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan COGS-to-Revenue?

Scinopharm Taiwan's Cost of Goods Sold for the three months ended in Mar. 2024 was NT$530 Mil. Its Revenue for the three months ended in Mar. 2024 was NT$883 Mil.

Scinopharm Taiwan's COGS to Revenue for the three months ended in Mar. 2024 was 0.60.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Scinopharm Taiwan's Gross Margin % for the three months ended in Mar. 2024 was 40.00%.

Scinopharm Taiwan COGS-to-Revenue Historical Data

The historical data trend for Scinopharm Taiwan's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinopharm Taiwan COGS-to-Revenue Chart

Scinopharm Taiwan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.59

0.57

0.54

0.62

Scinopharm Taiwan Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.62	0.63	0.65	0.59	0.60

Scinopharm Taiwan COGS-to-Revenue Calculation

Scinopharm Taiwan's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1970.094	/	3186.083
	=	0.62

Scinopharm Taiwan's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	529.913	/	883.226
	=	0.60

Scinopharm Taiwan (TPE:1789) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Scinopharm Taiwan's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	529.913 / 883.226
	=	40.00 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Scinopharm Taiwan COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan (TPE:1789) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Nan-Ke 8th Road, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144

Website

https://www.scinopharm.com

Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is primarily engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. Schinopharm also conducts consulting and technical services. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Scinopharm Taiwan (TPE:1789) Headlines

No Headlines